Status:

ACTIVE_NOT_RECRUITING

Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study

Lead Sponsor:

Shanghai 10th People's Hospital

Conditions:

Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)

Fecal Microbiota Transplantation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study enrolled 94 patients with UC or CD. Two groups received either 8-week intestinal bacterial transplant capsule therapy or biological therapy, respectively. The control group received biologi...

Eligibility Criteria

Inclusion

  • The diagnosis was UC or CD, and the diagnosis was based on clinical, endoscopic and pathological evidence.
  • IBD should be diagnosed for at least 6 months to rule out the possibility of natural remission of new cases.
  • Patients should be in mild to moderate active stage (UC: Mayo score 3-10; CD: CDAI score: 150-449)
  • Biological agents (such as anti-TNF-α drugs, vedolizumab, etc.) were used in the past, but no clinical remission was achieved.
  • Voluntary participation and signing of informed consent.
  • Adults aged 18-65.
  • Can tolerate oral enterobacteria transplantation capsule treatment.

Exclusion

  • The diagnosis was UC or CD, and the diagnosis was based on clinical, endoscopic and pathological evidence.
  • IBD should be diagnosed for at least 6 months to rule out the possibility of natural remission of new cases.
  • Patients should be in mild to moderate active stage (UC: Mayo score 3-10; CD: CDAI score: 150-449)
  • Biological agents (such as anti-TNF-α drugs, vedolizumab, etc.) were used in the past, but no clinical remission was achieved.
  • Voluntary participation and signing of informed consent.
  • Adults aged 18-65.
  • Can tolerate oral enterobacteria transplantation capsule treatment.

Key Trial Info

Start Date :

August 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2028

Estimated Enrollment :

94 Patients enrolled

Trial Details

Trial ID

NCT07149441

Start Date

August 1 2025

End Date

September 1 2028

Last Update

September 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China